LY2405319

DRUG2 trials

Sponsors

Eli Lilly and Company

Conditions

Diabetes Mellitus, Type 2Type 2 Diabetes

Phase 1

Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes

CompletedNCT00481117

Eli Lilly and CompanyType 2 Diabetes

Start: 2008-08-31End: 2008-12-31Updated: 2010-09-13

A Study of LY2405319 in Participants With Type 2 Diabetes

CompletedNCT01869959

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2009-04-30End: 2009-12-31Updated: 2017-03-20